MY01 Continuous Compartment Pressure Monitor

At LEDA Orthopaedics, we are committed to providing innovative solutions that elevate patient care and streamline clinical workflows. The MY01 Continuous Compartment Pressure Monitor redefines how clinicians manage Acute Compartment Syndrome (ACS), offering a reliable, real-time solution for early detection and intervention. 

Key Features 

Innovative technology designed to enhance clinical outcomes. 

• Continuous Monitoring: Tracks intracompartmental pressure in real time for up to 18 hours, providing clinicians with actionable data. 
• Wireless Integration: Seamlessly connects to a secure mobile app, enabling collaborative care across clinical teams. 
• Precision Placement: Intuitive introducer ensures accurate sensor positioning, reducing errors and improving reliability. 
• Single-Use Sterile Design: Simplifies preparation and eliminates cross-contamination risks. 
• Proven Performance: Clinically validated to enhance diagnostic accuracy and support better patient outcomes. 

The Challenges of Acute Compartment Syndrome (ACS) 

Acute Compartment Syndrome is a race against time. ACS develops when rising pressure within muscle compartments restricts blood flow, causing tissue and nerve damage. If left untreated, it can lead to devastating outcomes, including permanent disability, amputation, and even death. 

ACS is a true trauma emergency, but its detection often relies on physical exams and clinical observations that are often subjective, difficult to carry out, and error-prone. These limitations can result in: 

• Time-Sensitive Condition: Muscle necrosis can occur within two hours of the onset of ACS, with irreversible nerve damage often following soon after. 
• High Risk of Amputation: 5.7% of ACS cases result in amputation, with a lifetime cost exceeding £500,000 per patient. 
• Surgical Site Infections: Fasciotomies, while often necessary, carry a 25% risk of infection, adding an average of £20,000 to treatment costs. 
• Litigation Risks: Legal claims in the USA tied to delayed ACS diagnosis average $1.55 million in awarded damages, with rulings favouring patients in 33–55% of cases. 

Traditional diagnostic methods, such as assessing pain or physical symptoms, rely heavily on subjective judgement and often fail to provide reliable results. With MY01, clinicians gain access to continuous, real-time data, enabling faster and more confident decision-making during critical moments. 

How MY01 Works 

Reliable tools make all the difference in managing critical conditions like ACS. MY01 simplifies diagnosis with continuous pressure monitoring, wireless data integration, and an intuitive design that helps clinicians focus on providing the best care possible. 

1. Continuous Monitoring
   At the core of MY01 is a microsensor capable of continuously measuring intra-compartmental pressure for up to 18 hours. This real-time data supports early intervention and informed decision-making. 
2. Wireless Integration
   MY01 seamlessly connects to a secure mobile app, enabling real-time data transmission and collaborative care across clinical teams. 
3. Precision Placement
   The intuitive introducer ensures accurate sensor placement, reducing user error and improving reliability. 
4. Reliable and Predictable Results
   Continuous monitoring enables clinicians to track trends and act confidently, reducing unnecessary procedures or delayed treatment risks. 

Clinical Evidence Supporting MY01 

Managing ACS is a genuine challenge, but MY01 provides a proven path forward. Backed by extensive research and real-world application, this device supports clinicians in delivering better care. Clinical studies show that MY01 provides: 

• A reduction in the time to fasciotomy by six hours, allowing for earlier interventions and improved outcomes. 
• A significant decrease in the need for split-thickness skin grafts, from 50% to 15%. 
• Reduced incidence of unnecessary fasciotomies, resulting in cost savings for healthcare systems. 

Dr. Ed Harvey, Co-Founder of MY01, emphasises its impact:
“MY01 gives clinicians the confidence to diagnose ACS earlier and act decisively. It’s a critical tool for trauma care.” 

Interested in MY01?  

If you would like more information regarding MY01.